This report provides an overview of the cases of hepatitis of unknown origin in children aged 16 years and below reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).
The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
The key objective of this meeting was to verify the rationale and objectives of molecular typing for surveillance of hepatitis E virus (HEV) through the hepatitis E network (HEVnet). The workshop reviewed HEVnet as a tool for molecular surveillance of HEV in Europe.
The 31st IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress addressed the broad range of science and clinical practice in the field of sexually transmitted infections.
The aims of the meeting were to enable sharing of experiences and good practices between member states, review ECDC’s current programme of work and to help determine future priorities for surveillance, prevention and control of the hepatitis B virus (HBV) and hepatitis C virus (HCV) across Europe.
From 18 to 25 November 2016, almost 500 organisations all across Europe are hosting activities to increase awareness of the benefits of HIV and hepatitis testing.
The European Network for STI Surveillance comprises the contact points for STI surveillance that are nominated by the competent bodies for surveillance in EU/EFTA, and contains both epidemiological and microbiological experts.
HIV/AIDS surveillance in Europe is jointly coordinated by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, collecting data from all 53 countries in the European region.